Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency - Scorecard - MDSpire

Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

  • By

  • Lizzy Lawrence

  • March 6, 2026

  • 0 min

Share

Clinical Scorecard: Vinay Prasad's Departure from the FDA

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients requiring drug approvals, particularly those with rare diseases and vaccines.
Care Setting

Key Highlights

  • controversial_decisions

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • d
      • d
      • e
      • x
      • a
      • m
      • p
      • l
      • e
      • s
      • o
      • f
      • e
      • n
      • h
      • a
      • n
      • c
      • i
      • n
      • g
      • s
      • c
      • r
      • u
      • t
      • i
      • n
      • y
      • o
      • f
      • c
      • l
      • i
      • n
      • i
      • c
      • a
      • l
      • t
      • r
      • i
      • a
      • l
      • d
      • e
      • s
      • i
      • g
      • n
      • s
      • .

      Risks

        Patient & Prescribing Data

        Detail how regulatory decisions impact patient access to therapies.

        Clinical Best Practices

        • transparency

        References

        Original Source(s)

        Vinay Prasad, key Makary ally and a focus of controversy at the FDA, is leaving the agency

        • by Lizzy Lawrence

        • March 6, 2026

        Related Content

        Plasmonic COF Nanofilms Expand the Reach of Mass Spectrometry Imaging

        A gold-decorated covalent organic framework grown on titanium dioxide nanotubes enables matrix-free imaging across plants, fingerprints, fruits, and brain tissue

        • April 7, 2026

        • 2 min
        Toxic Metals Detected in Brazilian Children’s Toys

        ICP-MS analysis reveals widespread contamination and regulatory failures across 70 popular toys

        • January 2, 2026

        • 2 min
        Unlocking Hidden RNA Signals

        Targeted sequencing aids rare disease diagnosis

        • April 30, 2026

        • 3 min